Condition
COPD Exacerbation Acute clinical trials and research
As of November 12, 2026, Find a Trial lists 5 COPD Exacerbation Acute clinical trials that are recruiting, at sites in 4 countries (most in United Kingdom (2), Denmark (1), France (1)). By phase: Phase 4 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest COPD Exacerbation Acute clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Rademikibart IV for Acute Asthma and COPD Exacerbation | Phase 2 | Miami, Florida and 2 other locations | Recruiting | Jul 15, 2026 |
| Observational registry for COPD patients in ICU | — | Le Chesnay | Recruiting | Feb 17, 2023 |
| Titrated versus standard oxygen for prehospital treatment of COPD exacerbations | Phase 4 | Aarhus N | Recruiting | Jan 30, 2023 |
| Hospitalized adults with acute or chronic respiratory conditions: outcomes and recovery | — | Leicester | Recruiting | Oct 27, 2021 |
| Evaluating how high doses of prednisolone affect patients with inflammatory conditions | — | London | Recruiting | Aug 19, 2021 |
All recruiting trials (5)
-
Rademikibart IV for Acute Asthma and COPD Exacerbation
This study tests a one-time IV dose of rademikibart to help people with acute asthma or COPD flare-ups who need urgent care.
-
Observational registry for COPD patients in ICU
This study is looking at patients with severe COPD who are in the ICU to see how they are treated and what happens to them, in hopes of improving care for future patients.
-
Titrated versus standard oxygen for prehospital treatment of COPD exacerbations
This trial tests whether giving oxygen adjusted to keep blood oxygen (SpO₂) at 88–92% instead of using 100% oxygen during prehospital treatment of adults 40 and older with suspected COPD exacerbations lowers 30-day death.
-
Hospitalized adults with acute or chronic respiratory conditions: outcomes and recovery
This study tests how adults hospitalized with acute respiratory problems or chronic lung disease recover after discharge, and what factors predict readmission, stay length, and mortality.
-
Evaluating how high doses of prednisolone affect patients with inflammatory conditions
This study is trying to see how different doses of prednisolone affect patients with inflammatory conditions by looking at their blood levels and how their bodies process the medication.
Related topics
Quick answers
How many COPD Exacerbation Acute clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United Kingdom (2 trials), Denmark (1 trial), France (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.